T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Omega Healthcare
OHI
$13.9B
| $1.34M | ﹤0.01% |
33,150
| – | – |
|
1652
CNO Financial Group
CNO
$5.07B
| $1.34M | ﹤0.01% |
77,738
+941
| +1% | +$15.5K |
|
|
SPR
1653
DELISTED
Spirit AeroSystems
SPR
| $1.33M | ﹤0.01% |
25,500
+3,100
| +14% | +$148K |
|
|
UIL
1654
DELISTED
UIL HOLDINGS
UIL
| $1.31M | ﹤0.01% |
25,499
| – | – |
|
1655
Ryman Hospitality Properties
RHP
$7.87B
| $1.31M | ﹤0.01% |
21,489
+3,400
| +19% | +$197K |
|
1656
Suncor Energy
SU
$76.5B
| $1.31M | ﹤0.01% |
44,800
-430,155
| -91% | -$12.8M |
|
1657
Lamar Advertising Co
LAMR
$15.8B
| $1.3M | ﹤0.01% |
21,992
| – | – |
|
|
DHC
1658
Diversified Healthcare Trust
DHC
$2.03B
| $1.29M | ﹤0.01% |
58,738
| – | – |
|
1659
Webster Financial
WBS
$12.8B
| $1.29M | ﹤0.01% |
34,813
+7,900
| +29% | +$265K |
|
1660
Nabors Industries
NBR
$1.35B
| $1.28M | ﹤0.01% |
1,875
-8,811
| -82% | -$5.37M |
|
1661
DigitalBridge
DBRG
$2.94B
| $1.28M | ﹤0.01% |
13,702
-7
| -0.1% | -$634 |
|
|
IM
1662
DELISTED
Ingram Micro
IM
| $1.27M | ﹤0.01% |
50,569
+455
| +0.9% | +$11.6K |
|
1663
Celldex Therapeutics
CLDX
$3.35B
| $1.27M | ﹤0.01% |
3,035
| – | – |
|
|
ALR
1664
DELISTED
Alere Inc
ALR
| $1.27M | ﹤0.01% |
25,940
| – | – |
|
|
NSM
1665
DELISTED
Nationstar Mortgage Holdings
NSM
| $1.27M | ﹤0.01% |
51,100
-12,500
| -20% | -$343K |
|
|
OA
1666
DELISTED
Orbital ATK, Inc.
OA
| $1.24M | ﹤0.01% |
16,164
+7,439
| +85% | +$704K |
|
1667
TSMC
TSM
$2.23T
| $1.23M | ﹤0.01% |
52,568
-794,248
| -94% | -$18.7M |
|
1668
Enbridge
ENB
$112B
| $1.22M | ﹤0.01% |
25,400
+1,000
| +4% | +$48.1K |
|
|
CTB
1669
DELISTED
Cooper Tire & Rubber Co.
CTB
| $1.22M | ﹤0.01% |
28,500
-2,600
| -8% | -$96.1K |
|
1670
Curtiss-Wright
CW
$25.4B
| $1.22M | ﹤0.01% |
16,500
| – | – |
|
1671
The GEO Group
GEO
$4B
| $1.21M | ﹤0.01% |
41,576
-2,124
| -5% | -$60.6K |
|
1672
Hallador Energy
HNRG
$730M
| $1.21M | ﹤0.01% |
+103,591
| New | +$1.2M |
|
1673
World Acceptance Corp
WRLD
$875M
| $1.21M | ﹤0.01% |
16,600
-3,200
| -16% | -$258K |
|
1674
Bank of Montreal
BMO
$129B
| $1.21M | ﹤0.01% |
20,177
+1,777
| +10% | +$110K |
|
1675
Huntsman Corp
HUN
$1.81B
| $1.2M | ﹤0.01% |
54,000
-7,715
| -13% | -$172K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.